MNA: Baystate Noble Hospital Nurses to Deliver Petition on May 29 Urging Management to Address Unsafe Staffing and Patient Care Conditions Signed by Nearly 100% of RNs
A petition signed by Noble Hospital nurses calls on Baystate executives to settle a fair contract with solutions aimed at fixing alarming safety and staff morale problems WESTFIELD, Mass., May 28, 2024 /PRNewswire/ — Registered nurses at Baystate Noble Hospital, represented by the Massachusett
JPAR® Affiliate Network Welcomes Raintown Realty +JPAR to its Growing Network
Pacific Northwest firm stands out for its tech-focused services, catering to both first-time buyers and sellers with a strong emphasis on exceptional client experiences PLANO, Texas, May 28, 2024 /PRNewswire/ — JPAR®, a leading real estate brand, announced today the newest addition to its a
Claros Technologies, Inc. Raises $22 Million to Accelerate PFAS Destruction and Analytical Technologies
MINNEAPOLIS, May 28, 2024 /PRNewswire/ — Claros Technologies, Inc. (ClarosTech™), the leader in PFAS analytical and destruction technologies, announced today that it has raised $22M in new funding co-led by Ecosystem Integrity Fund and American Century Investments. This financing will allow
(included) CPG Returning to Specialty Food Association 2024 Summer Fancy Food Show
NEW YORK, May 28, 2024 /PRNewswire/ — Following an impactful showing for its cohort at the Specialty Food Association (SFA)’s Winter Fancy Food Show, (included) CPG, a collective of BIPOC founders and executives in consumer packaged goods, will return to the Summer Fancy Food Show in Ju
Shareholder Alert: Ademi LLP investigates whether Atrion Corporation has obtained a Fair Price for its Public Shareholders in its transaction with Nordson
MILWAUKEE, May 28, 2024 /PRNewswire/ — Ademi LLP is investigating Atrion (Nasdaq: ATRI) for possible breaches of fiduciary duty and other violations of law in its transaction Nordson. Click here to learn how to join the https://www.ademilaw.com/case/atrion-corporation or call Guri Ademi toll-
Unravel Biosciences Receives FDA Orphan Drug Designation for Vorinostat (RVL-001) as a Treatment for Rett Syndrome
Initiation of global clinical development program for RVL-001 in Rett syndrome underway, with recently announced Rett studies in the US led by Vanderbilt and in Colombia led by Unravel. BOSTON, May 28, 2024 /PRNewswire/ — Unravel Biosciences, Inc., (“Unravel”), an AI-enabled therap
Lucinity Wins the Microsoft Partner Awards for 2024 for Partner of the Year – Iceland and Sustainability and Social Impact
REYKJAVÍK, Iceland, May 28, 2024 /PRNewswire/ — Lucinity, a leading AI company for financial crime prevention, won two awards at the Microsoft Partner Awards for 2024, including Partner of the Year – Iceland and Sustainability and Social Impact, highlighting Lucinity’s innovation
2024 Hengqin Global Investment Promotion Conference Kicks Off
HENGQIN, China, May 28, 2024 /PRNewswire/ — The Hengqin 2024 Global Investment Promotion Conference and sharing sessions opened on 26 May. Liu Xianfa, Commissioner of China’s Foreign Ministry in the Macao SAR; Lei Wai Nong, Director of the Executive Committee of the Guangdong-Macao In-
DRIVERS AT 10 ROADS EXPRESS IN NORTH CAROLINA JOIN TEAMSTERS
Organizing Momentum Fuels Freight Drivers at USPS’s Second-Largest Contractor GREENSBORO, N.C., May 28, 2024 /PRNewswire/ — Drivers at 10 Roads Express in Greensboro, N.C., have voted overwhelmingly to join Teamsters Local 391. The group of 54 workers is seeking higher wages, bet
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® (golimumab) Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2506 STADA will have exclusive rights to commercialize the produc
